eprintid: 654
rev_number: 18
eprint_status: archive
userid: 2
dir: disk0/00/00/06/54
datestamp: 2011-06-30 14:25:27
lastmod: 2014-07-02 10:38:17
status_changed: 2014-07-02 10:38:17
type: book_section
metadata_visibility: show
item_issues_count: 0
creators_name: Arora, Ashish
creators_name: Gambardella, Alfonso
creators_name: Pammolli, Fabio
creators_name: Riccaboni, Massimo
creators_id: 
creators_id: 
creators_id: f.pammolli@imtlucca.it
creators_id: massimo.riccaboni@imtlucca.it
title: The nature and extent of the market for technology in biopharmaceuticals
ispublished: pub
subjects: HB
subjects: HD28
divisions: EIC
full_text_status: none
keywords: Innovation, Markets for technology, Biopharmaceutical Industry, R&D Collaboration
abstract: The biopharmaceutical industry is a typical example of the development of technological collaborations, as well as of technological competition, between larger established firms and smaller high-tech specialist firms (the so-called New Biotechnology Firms — NBFs). These two types of firms perform innovative activities at different stages, with different degree of risk, and with different probability of failure. By using a comprehensive database of 2078 drug R&D projects promoted all over the world during the 1990s, this study assesses the different performance of R&D processes conducted under different governance structures, most notably projects that are fully internalised by the companies vis-àvis projects developed in collaboration with other firms. Moreover, this study compares the different specialisation and performance of large drug companies with respect to the NBFs. Results show that the established pharmaceutical companies have comparative advantages with respect to NBFs in drug development, while there is no advantage related to scale in drug discovery. Furthermore, NBFs undertake less risky project, which are more likely to fail at earlier clinical stages.
date: 2004
date_type: published
publisher: Kluwer Academic Publishers
pagerange: 175-202
pages: 330
id_number: 10.1007/978-1-4020-7942-9_8
refereed: TRUE
isbn: 978-1-4020-7866-8
book_title: Fabrizio Cesaroni, Alfonso Gambardella and Walter A. Garcia-Fontes (eds.). R&D, Innovation and Competitiveness in the European Chemical Industry R&D, Innovation and Competitiveness in the European Chemical Industry
editors_name: Cesaroni, Fabrizio
editors_name: Gambardella, Alfonso
editors_name: Garcia-Fontes, Walter A.
official_url: http://dx.doi.org/10.1007/978-1-4020-7942-9_8
citation:   Arora, Ashish and Gambardella, Alfonso and Pammolli, Fabio and Riccaboni, Massimo  The nature and extent of the market for technology in biopharmaceuticals.   In:  Fabrizio Cesaroni, Alfonso Gambardella and Walter A. Garcia-Fontes (eds.). R&D, Innovation and Competitiveness in the European Chemical Industry R&D, Innovation and Competitiveness in the European Chemical Industry.   Kluwer Academic Publishers, pp. 175-202.  ISBN 978-1-4020-7866-8      (2004)